Innovent Biologics
Developing, manufacturing cancer medicines
- B2B
About Innovent Biologics
Innovent focuses on developing, manufacturing, and commercializing innovative medicines for cancer and other major diseases, with a robust pipeline of assets
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 251–1,000 employees
- Headquarters
- suzhou, jiangsu, China
- Founded
- 2011
- Revenue
- CNY 13BFY2025, publicly reported
- Website
- innoventbio.com
Innovent Biologics at a glance
Innovent Biologics is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in suzhou, jiangsu, China.
Innovent Biologics was founded in 2011.
Innovent Biologics has 251–1,000 employees.
Innovent Biologics's revenue is CNY 13B (FY2025, publicly reported).
Frequently asked questions about Innovent Biologics
What is Innovent Biologics's revenue?
Innovent Biologics's revenue is CNY 13B (FY2025, publicly reported).
How many employees does Innovent Biologics have?
Innovent Biologics has 251–1,000 employees.
Where is Innovent Biologics headquartered?
Innovent Biologics is headquartered in suzhou, jiangsu, China.
Selling to companies like Innovent Biologics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies